These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 22593849)

  • 41. Factors affecting women's preference for type of prenatal screening test for chromosomal anomalies.
    Spencer K; Aitken D
    Ultrasound Obstet Gynecol; 2004 Dec; 24(7):735-9. PubMed ID: 15505874
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Community-based screening for Down syndrome in the first trimester using ultrasound and maternal serum biochemistry.
    Gyselaers WJ; Vereecken AJ; Nijhuis JG
    BJOG; 2006 Mar; 113(3):362; author reply 363-4. PubMed ID: 16487214
    [No Abstract]   [Full Text] [Related]  

  • 43. Repeated measurement of pregnancy-associated plasma protein-A (PAPP-A) in Down syndrome screening: a validation study.
    Palomaki GE; Wright DE; Summers AM; Neveux LM; Meier C; O'donnell A; Huang T; Knight GJ; Haddow JE
    Prenat Diagn; 2006 Aug; 26(8):730-9. PubMed ID: 16810709
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Systematic proposal and obligation of information in Down syndrome screening].
    Grangé G; Azria E
    J Gynecol Obstet Biol Reprod (Paris); 2008 Oct; 37(6):535-7. PubMed ID: 18760548
    [No Abstract]   [Full Text] [Related]  

  • 45. First-trimester screening for trisomy 21 in Denmark: implications for detection and birth rates of trisomy 18 and trisomy 13.
    Ekelund CK; Petersen OB; Skibsted L; Kjaergaard S; Vogel I; Tabor A;
    Ultrasound Obstet Gynecol; 2011 Aug; 38(2):140-4. PubMed ID: 21229566
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple marker screening for Down syndrome in the first trimester of pregnancy.
    Wallace EM
    Aust N Z J Obstet Gynaecol; 1997 Aug; 37(3):368-70. PubMed ID: 9325534
    [No Abstract]   [Full Text] [Related]  

  • 47. Comparison of combined, stepwise sequential, contingent, and integrated screening in 7292 high-risk pregnant women.
    Guanciali-Franchi P; Iezzi I; Palka C; Matarrelli B; Morizio E; Calabrese G; Benn P
    Prenat Diagn; 2011 Nov; 31(11):1077-81. PubMed ID: 21800336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Maternal serum free beta-hCG and PAPP-A in patients with habitual abortion-influence on first-trimester screening for chromosomal abnormalities.
    Heinig J; Steinhard J; Schmitz R; Nofer JR; Kiesel L; Klockenbusch W
    Prenat Diagn; 2007 Sep; 27(9):814-6. PubMed ID: 17554803
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antenatal screening for Down syndrome.
    Wald NJ
    Prog Clin Biol Res; 1995; 393():27-42. PubMed ID: 8545455
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Detection of trisomy 21 in a fetus during the investigation for Tay-Sachs disease.
    Alpman A; Bora E; Karaca E; Cankaya T; Onay H; Cogulu O; Gunduz C; Kleijer WJ; Ozkinay F
    Genet Couns; 2004; 15(1):99-100. PubMed ID: 15083708
    [No Abstract]   [Full Text] [Related]  

  • 51. Early decision. Will new advances in prenatal testing shrink the ranks of babies with Down syndrome?
    Rochman B
    Time; 2012 Feb; 179(8):36-40. PubMed ID: 22462306
    [No Abstract]   [Full Text] [Related]  

  • 52. A parent's guide to the genetics of Down syndrome.
    Hartway S
    Adv Neonatal Care; 2009 Feb; 9(1):27-30. PubMed ID: 19212162
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of smoking on maternal serum markers and prenatal screening in the first and second trimesters.
    Zhang J; Lambert-Messerlian G; Palomaki GE; Canick JA
    Prenat Diagn; 2011 Jun; 31(6):583-8. PubMed ID: 21480302
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cross-trimester marker ratios in prenatal screening for Down syndrome.
    Wald NJ; Bestwick JP; Morris JK
    Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Maternal weight and ethnic adjustment within a first-trimester Down syndrome and trisomy 18 screening program.
    Krantz DA; Hallahan TW; Macri VJ; Macri JN
    Prenat Diagn; 2005 Aug; 25(8):635-40. PubMed ID: 16049986
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
    Benn PA; Ying J; Beazoglou T; Egan JF
    Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening for trisomy 21 in Flanders: a 10 years review of 40.490 pregnancies screened by maternal serum.
    Gyselaers WJ; Vereecken AJ; Van Herck EJ; Straetmans DP; Martens GE; de Jonge ET; Ombelet WU; Nijhuis JG
    Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):185-9. PubMed ID: 15262353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prenatal diagnosis now and in the future, in a genetic perspective.
    Wahlström J
    Acta Obstet Gynecol Scand; 2000 Nov; 79(11):925-7. PubMed ID: 11081672
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
    Skotko B
    Obstet Gynecol; 2006 May; 107(5):1170. PubMed ID: 16648429
    [No Abstract]   [Full Text] [Related]  

  • 60. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.